Ziwig, a French biotech company committed to advancing women’s health, announces the fast-track reimbursement of Ziwig Endotest – the first saliva diagnostic test for endometriosis- for 25 000 patients across 80 medical centers in France thanks to the Innovation Funding Feb 11 decree.
Health Technology Insights: Kalos Health & VNS Health Expand Long-Term Care Access
French health authorities for healthcare to take a major step towards improving diagnosis of endometriosis by fast-tracking reimbursement for patients for Ziwig Endotest a reliable and non-invasive diagnosis tool with results available within a few days.
Health Technology Insights: Swedish Region Expands Sectra’s Digital Pathology for Cancer
Endometriosis affects 1 in 10 women worldwide. The variety and scope of symptoms can significantly alter women’s health, quality of life and fertility. Ending medical wandering –evaluated between 7 to 10 years– is key to improve care, quality of life and fertility.
Health Technology Insights: Earnest Analytics Unveils Hydrus Medical Claims Dataset
To participate in our interviews, please write to our HealthTech Media Room at news@intentamplify.com
Source – prnewswire